Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor

PHASE3CompletedINTERVENTIONAL
Enrollment

734

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Alzheimer's Disease
Interventions
DRUG

Placebo

Once daily, matching placebo capsules, orally

DRUG

Idalopirdine

Once daily, encapsulated tablets, orally

Trial Locations (107)

Unknown

US612, Mesa

US625, Bellflower

US626, Costa Mesa

US604, Oxnard

US627, Santa Ana

US609, Danbury

US614, Norwalk

US608, Deerfield Beach

US616, Hialeah

US620, Miami

US603, North Palm Beach

US631, Port Charlotte

US622, Elk Grove Village

US611, Elkhart

US606, Prairie Village

US601, Farmington Hills

US607, St Louis

US613, Lawrenceville

US635, Paterson

US630, Toms River

US621, Albany

US632, Staten Island

US633, Charlotte

US623, Oklahoma City

US618, Norristown

US619, Houston

AU603, Caulfield

AU609, Glen Iris

AU602, Heidelberg West

AU604, Kanwal

AU606, Newcastle

AU601, West Perth

AU610, Woodville South

BR608, Belo Horizonte

BR609, Itapira

BR607, Rio de Janeiro

CZ602, Choceň

CZ608, Choceň

CZ605, Havlíčkův Brod

CZ606, Kladno

CZ603, Pilsen

CZ601, Prague

CZ604, Prague

CZ607, Praha 10 - Strasnice

DE612, Bad Homburg

DE610, Bad Honnef

DE609, Berlin

DE617, Berlin

DE604, Erbach im Odenwald

DE611, Freiburg im Breisgau

DE607, Gelsenkirchen

DE605, Homburg

DE608, Karlstadt am Main

DE602, Mittweida

DE601, Munich

DE606, Rostock

DE603, Ulm

DE616, Unterhaching

IL605, Bat Yam

IL601, Haifa

IL604, Holon

IL602, Ramat Gan

IL603, Tel Aviv

MX602, México

MX601, Monterrey

MX603, Monterrey

MX604, Monterrey

MX605, Monterrey

MX606, Saltillo

RS602, Belgrade

RS603, Kragujevac

RS601, Novi Sad

SG601, Singapore

SG602, Singapore

SK601, Banská Bystrica

SK603, Bratislava

SK605, Bratislava

SK604, Rimavská Sobota

SK602, Svidník

KR601, Seongnam-si

KR602, Seoul

KR603, Seoul

KR604, Seoul

ES601, Barcelona

ES603, Barcelona

ES604, Barcelona

ES608, Barcelona

ES611, Bilbao

ES612, Burgos

ES602, Lleida

ES613, Madrid

ES610, Sant Cugat del Vallès

ES606, Seville

ES605, Terrassa

ES607, Valencia

CH603, Biel

CH605, Lausanne

CH602, Les Acacias

CH601, Schlieren

TR602, Balova

TR601, Istanbul

TR603, Istanbul

TR605, Istanbul

TR606, Izmir

TR607, Samsun

GB601, Brentford

GB603, Northampton

Sponsors
All Listed Sponsors
collaborator

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY

lead

H. Lundbeck A/S

INDUSTRY

NCT02006654 - Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor | Biotech Hunter | Biotech Hunter